The effectiveness evaluation of a multimedia hepatitis C prevention program for Hispanic HIV-infected individuals by Mayor, Angel M. et al.
The effectiveness evaluation of a multimedia hepatitis C
prevention program for Hispanic HIV-infected individuals
Angel M. Mayor, MD
Retrovirus Research Center, Internal Medicine Department, Universidad Central del Caribe,
School of Medicine (AMM)
Diana M. Fernández, EdD
Retrovirus Research Center, Internal Medicine Department, Universidad Central del Caribe,
School of Medicine (DMF)
Héctor M. Colón, PhD
Center for Addiction Study, Universidad Central del Caribe, School of Medicine (HMC)
James C. Thomas, PhD
Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill,
NC (JCT)
Robert F. Hunter-Mellado, MD
Retrovirus Research Center, Internal Medicine Department, Universidad Central del Caribe,
School of Medicine (RFH)
Abstract
Introduction—With the introduction of highly active antiretroviral therapy the Hepatitis C virus
(HCV) infection has became a primary health problem among individuals suffering from HIV/
AIDS in Puerto Rico, principally those who are injecting drug users (IDUs). A multimedia
educational intervention, based on the Health Beliefs Model and Social Cognitive Theory was
developed and implemented to reduce HCV associated risk behaviors among IDUs.
Methods—A pre- and post- intervention study evaluated the knowledge and behavioral changes
in a group of HIV-infected persons recruited from February 2006 through December 2008.
Results—A total of 110 participants were recruited; all were IDUs; 82% were men; 86.3% were
HIV/HCV co-infected and 24.5% had active injected drugs in the last month (prior to
recruitment). The group mean age was 42.2 ± 9.2 years and mean educational level was 10th
grade. Knowledge of HCV risk behaviors, perception of HCV susceptibility, and perception of
disease severity increased after the intervention. Knowledge of HCV clinical manifestations and
HIV co-infection complications and treatment also improved. In addition, HCV risk behaviors and
injecting drug practice decrease significantly among IDUs.
Conclusions—This new multimedia intervention captured and maintained the participants'
attention and interest, in that way facilitating their educational process. Thus, a greater of attention
and interest leads to greater knowledge and prevention improvement.
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With the introduction of highly active antiretroviral therapies (HAART), the Hepatitis C
virus (HCV) infection has become a major contributor to the prognosis of HIV- infected
subjects.1–3 HIV/HCV infection are blood pathogens that share several risk factors for
transmission. 4–6 For a large majority of co-infected individuals injecting drug use (IDU) is
the risk factor for the infections.1–4, Consequently, the rate of HCV co-infection in injecting
drug users (IDUs) may exceed 80%.
In the absence of a vaccine or an effective prophylactic therapy for HCV infection,
preventive strategies that limit the spread of this viruse is been considered as an important
step in diminishing the target organ damage that is often seen in co-infected individuals.7,8
Steps to initiate prevention programs in this population have stumbled because of such
difficulties as diminished reading skills, and a diminished understanding of the relevance of
the information. In addition, the issues of prevention will necessitate IDU modifications that
imply changes in lifestyle and the implementation of practices that are inherently complex in
nature.9
The use of images, figures, and animated presentations focused on specific learning
objectives may be better received and understood by individuals in this particular at risk
group. 10–12 We have developed a multimedia HCV preventive intervention for Hispanic
HIV-infected, IDUs from Puerto Rico.13 This intervention was based on the Health Belief
Model (HBM) and the Social Cognitive Theory (SCT) that are theoretical frameworks
frequently used in the design of educational and health related interventions.14–16 We have
previously published data which suggests the feasibility and acceptability of this program in
this high-risk population.13 The current study assess the effectiveness of this intervention in
the selected cohort of patients.
METHODS
Study enrollment
The study was conducted over a two-and-a-half-year period between February 2006 and
December 2008. Individuals targeted for this intervention were HIV-infected IDUs over 21
years visiting the Retrovirus Research Center in Bayamón, Puerto Rico, for HIV-related
care. Every other IDUs participant that visited the center during the study period was invited
to participate in the intervention. The remaining IDUs received the intervention at the end of
the study, to avoid ethical issues.
After the initial recruitment and before each computerized intervention session, each
participant received a 10-minute orientation on how to use the computer and navigate the
program. Subsequently, a computer-based intervention was administered under the
supervision and assistance of the health educator. The first session was offered immediately
upon recruitment ; the others, two, four and eight weeks after. The last session was designed
to reinforce the previous interventions. All participants were tested for HCV before
participating in the study.
Intervention theoretical frame
The intervention was developed using Power-Point software and includes text, cartoons,
pictures and an audio tutorial. Each session was designed to be completed within 25 to 35
minutes. The theoretical frameworks guiding the intervention design were the HBM and
SCT.14–16 The HBM describes the relationships between the essential factors involved in
behavioral change. Our intervention sessions focused on increasing HCV knowledge, HCV
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susceptibility perception, and HCV protective measure efficacy. SCT addresses four
components of learning: attention, retention, reproduction, and motivation.15,16 As described
in our previous publication, the multimedia tools used in our intervention attract individual
attention, thereby improving retention and the ability to reproduce or copy a modeled
behavior.13 Of particular importance were the personal motivations for behavior change,
including perceptions of risks and benefits of behavior changes. Moreover, we anticipated
that the installments of the intervention would provide reinforcement of the message, further
enhancing retention, reproduction and motivation for behavior change.
Intervention content and form
The first session was designed to increase HCV knowledge focusing both on HCV as a
health problem and on its adverse effects in the prognosis of HIV-infected patients. The
second session was designed to increase the perception of susceptibility to HCV infection.
The third session taught participants about HCV risk behaviors and prevention strategies.
And the final session reinforced the importance of HCV prevention. Before the study
implementation, all sessions were reviewed and evaluated by an expert panel composed of
two primary physicians, one gastroenterologist and one education professor, who concurred
that the content and form of the intervention were adequate and covered the primary goals of
the study.
Effectiveness evaluation
With the help of a self-administrated-questionnaire developed from preexisting adapted
instruments,17–20 the study evaluated the HCV knowledge, and perception of severity and
susceptibility as well as the injecting drug risk-behaviors and patterns in the study group
before and after the intervention. The instrument included Likert scales beside other
measures to evaluate the study domains. Perceptions of severity, susceptibility and self-
confidence were measure using a scale that range from “0” (none) to “10” (high). Similarly
the frequency of HCV risk behaviors was measured on a scale ranging from “0” (never) to
“10” (always). Pre- and post-intervention tests were performed to explore changes. The post
evaluation was performed at week eight, just before the reinforcement session.
Statistical analysis
The Statistical Package of Social Sciences (SPSS Inc., Chicago IL) program was used to
conduct univariate and bivariate analyses. Univariate analysis was used to evaluate the
percentage and means distributions. The Mc Nemar test, the pair t test and the Wilcoxon




During the study period 138 patients entered in the study, and 110 completed all fourth
sessions. Of the 110 HIV- infected participants, 90 (81.8%) were male, all had history of
IDU and 96 (86.3%) were co-infected with HCV. Of the male participants, 12.2% reported
sex with another man. The mean age was 42.2 years ± 9.3 years. The mean educational level
was 10th grade. Almost half of the participants (47.3%) reported having IDU in the six
months prior to study enrollment. The HIV mean disease duration was 5.2 ±5.0 years;
21.8% had CD4+T cell count < 200 cells/μl and 20.0% had received HAART at enrollment
or in the previous 12 months.
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Hepatitis and HCV knowledge changes
In evaluating of the knowledge acquired regarding the liver function no significant changes
was detected in the pre- and post-intervention patients' assessment. In spite of the fact that
before intervention over 92% of the participants already knew that HCV was found
predominantly in blood, there was an improved knowledge regarding viral distribution in
body fluids. Similarly, there was a slight increase in the already high levels of knowledge
evidence regarding HCV-infection-associated risk behaviors (e.g., injecting drug, sharing
razors, making tattoos, doing piercings). The misconceptions that coughing, sneezing,
sharing food or utensils, contributes to the spread of HCV decreased significantly after the
intervention (Table 1). Conversely, there was a significantly increase in identification of
cocaine sniffing as an HCV-infection risky behavior. The study found there to be an
incremental in the level of knowledge regarding HCV clinical manifestations, treatment, and
co-infection with HIV after the intervention. The differences were more significant in the
areas relating to the lack of a vaccine and the complication of co-infection.
HCV perception of severity and susceptibility changes
At study entry participants had high levels of awareness regarding the severity of HCV
infection as a health care condition; however this awareness was increased significantly after
completing the interventions (Table 2). Similarly, the awareness that viral infection causes
damage to the liver, which in turn influences survival was also augment after the
intervention (though this difference did not reach statistical significance). The understanding
of the severity of HCV-HIV co-infection, which at baseline was already high, did not
increase after the intervention (Table 2). In the evaluation of the perceived susceptibility of
becoming infected with HCV, we found an incremental increase in the knowledge that one
can become co-infected when sharing paraphernalia used in the preparation and disposition
of injecting drugs and when sharing paraphernalia used for sniffing cocaine. Nevertheless,
these differences did not reach statistical significance (Table 2).
HCV risk-behaviors changes
We found a significant reduction in the practice of active IDU (in the previous month) after
the intervention (24.5% vs. 13.6%, respectively). Those individuals who remained active in
IDU reported an improvement in their HCV risk-reduction behavior. The frequenting of
shooting galleries and the use of potentially contaminated injecting paraphernalia were less
often reported in these persons, though these differences did not reach statistical significance
(Table 3).
Self confidence changes in reducing HCV risk-behaviors
The degree of self confidence of the participants in avoiding HCV risk-behaviors increased
after the intervention (Table 4). Baseline data showed a high level of self-assurance
regarding participants' estimations of their abilities to avoid the HCV risk-behaviors. Still,
participants showed an improvement in their levels of self-confidence regarding the ability
to avoid sharing filters, cookers, syringes and water. The study subjects reported a reduction
in their self-belief that used syringes were clean if macroscopic blood could not be seen
inside them (Table 4).
DISCUSSION
The purpose of this paper is to present data that show a measurable change in HCV
awareness in IDUs immediately after their having been exposed to a multimedia educational
intervention. The most important results are that we can measure and document an
improvement in HCV knowledge and show that participants gained a better understanding
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of the severity of and their individual susceptibility to the HCV infection. In addition, a
reduction of HCV risk-behavior and an improvement in the subjects' self-confidence
regarding their abilities to avoid HCV risk behavior was observed. These findings suggests
that multimedia interventions based on the HBM and SCT theoretical frameworks is a viable
approach to health related behavior changes for high risk Hispanic populations. These
behavioral theories attract the individual attention; thereby improving retention and the
ability to reproduce or copy a modeled behavior.15,16
As previously reported by others authors10–12 multimedia intervention has the potential
advantage of being capable of addressing a wide range of health-related issues and affecting
the knowledge and behaviors of high-risk population. Computer-based strategies offer an
opportunity for systematically exposing high-risk individuals to individually relevant,
effective health promotion messages.10–13 Advances in computer software and hardware
allowed us to create and implement a user-friendly multimedia intervention program that
overcame the potential barriers that would have limited the delivery of messages to members
of the studied population, with their generally limited formal educations. The use of
cartoons, pictures, and audio narration that described in detail the most common risk-
behaviors and rituals performed by IDUs when preparing, administering, and sharing drugs
facilitated the learning process and the subsequent incorporation of HCV-infection
preventive behaviors in this high-risk population. The principal goal of our intervention was
to increase the participants' motivation to self-implement behavioral changes based on
improved knowledge and risk perception. The multimedia intervention strategy we used was
able to capture and maintain the participants' attention, in turn facilitating the educational
process. Improved attention skills and a higher interest lead to greater knowledge and an
improvement in the preventive practices required. We believe our data suggests that this
improvement occurred in the study group. The content of the multimedia presentation
attracted the participants' attention and augmented knowledge retention, improving their
ability to practice the desired preventive behaviors modeled therein, as postulated by the
HBM.14 Our interpretations could explain the significant reduction of active IDU, despite
the fact that this outcome was not the principal goal of the educational intervention.
However, we have to consider the possibility that this finding could be influenced by an
individual ambition to give socially desirable answers.
Our findings verify the potential benefit of multimedia programs for the dissemination of
HCV prevention strategies in a Hispanic high-risk population. This type of intervention
could easily and inexpensively be disseminated via the internet to a wide number of health
care providers and/or health educators for a number of clinical uses.
Our study has the following limitations. 1) Low prevalence of HIV mono-infection in the
study sample could have affected the statistical power that evaluates changes in the
perception of disease infection susceptibility. 2) Similarly, a low prevalence of active IDU in
the study group could have limited the evaluation of the program's goal, i.e., the reduction in
HCV infection risk behavior. For the future this multimedia intervention would need to be
implemented in a group at an earlier stage of drug addiction and in a group with a higher
level of active injecting drug used in order to confirm the preventive trend found in this
study.
Our computer-based intervention appears to decrease HCV risk behaviors among HIV-
IDUs. The introduction of preventive strategies in this hard-to-reach population may
ultimately serve to decrease the hard to control health-care disparity in this group of patients.
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Table 1
Results of Pre/Post testing: HCV-infection knowledge
Parameter (n=110) Intervention
Pre (%) Post (%) p-value
Knowledge of liver, hepatitis and HCV
 The liver has metabolic functions 67.3 69.1 0.87
 Hepatitis means liver damage or harm 87.3 98.2 0.01*
 HCV-infection is a viral condition 73.1 85.2 0.03*
Knowledge of HCV location
 HCV is predominantly in blood 92.7 95.4 0.55
 HCV is not predominantly in urine 67.0 82.6 0.01*
 HCV is not predominantly in stools 73.4 81.7 0.18
 HCV is not predominantly in semen 60.6 70.6 0.10
Knowledge of HCV risk behaviors
 Reuse of syringes during drug injection 99.1 97.2 0.63
 Reuse cooker or cotton during drug injection 81.7 90.8 0.09
 Sharing paraphernalia for cocaine sniffing 56.9 84.4 0.01*
 Perform tattoos under unhygienic conditions 92.7 90.8 0.82
 Perform unhygienic body piercings 87.0 88.0 1.00
 Sharing razors 84.4 85.3 1.00
 Coughing and sneezing 35.8 14.7 0.01*
 Food preparation 13.9 5.6 0.04*
 Sharing eating utensils 45.9 21.1 0.01*
 Sex with a person infected with HCV 81.1 83.5 0.84
 Man having sex with man 57.4 39.8 0.01*
Knowledge of HCV and HCV/HIV co-infection
 Not all HCV-infected persons have symptoms 55.0 61.5 0.23
 Some HCV patients develop liver cirrhosis 90.0 89.1 1.00
 HCV therapy are available 60.9 69.1 0.22
 HCV treatment could affect HIV treatment 32.7 49.1 0.02*
 HCV vaccine is not available 35.5 51.8 0.01*
 Not all HCV treated persons are cured 73.4 75.2 0.86
 HCV/HIV co-infection is worse than single infection 61.8 72.1 0.07
 HCV therapy is not effective for HIV-infection 87.3 90.0 0.63
 Not all HCV/HIV persons can receive HCV therapy 23.6 36.4 0.05*
HCV= Hepatitis C virus
*
p value < .05 by Mc.Nemar test
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Table 2
Results of Pre/Post testing: Perception of severity and susceptibility of HCV disease
Parameter Pre-intervention Median (IQR) Post-intervention Median (IQR)
Perception of HCV-infection severity (n=110)
HCV infection is a severe disease 10.0 (7.0–10.0) 10.0 (8.0–10.0)*
HCV infection can cause death 7.0 (5.0–10.0) 7.0 (5.0–10.0)
HCV infection can cause liver cirrhosis 9.0 (6.0–10.0) 8.0 (6.0–10.0)
HCV/HIV co-infection can cause death 10.0 (6.0–10.0) 8.0 (6.0–10.0)
HCV infection can cause liver cancer 8.0 (5.0–10.0) 7.0 (6.0–10.0)
Perception of HCV-infection susceptibility in HCV (−)
participants. (n=10)
Develop HCV and HIV co-infection 5.5 (0.0–9.3) 5.0 (2.5–10.0)
Develop HCV by sharing drug preparing paraphernalia 9.0 (3.0–9.0) 10.0 (5.7–10.0)
Develop HCV by back load syringe 10.0 (9.7–10.0) 10.0 (6.0–10.0)
Develop HCV by tattooing or making body piercing 10.0 (6.2–10.0) 9.0 (4.0–10.0)
Develop HCV by sharing cocaine sniffing paraphernalia 6.5 (3.5–10.0) 9.5 (5.0–10.0)
HCV= Hepatitis C virus
IQR= Inter quartile range
HIV(−) = HIV negative
*
p value<.05 by Wilcoxon test
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Table 3
Results of Pre/Post testing: HCV-infection risk behaviors in active IDUs
Parameter Pre-intervention Median (IQR) Post-intervention Median (IQR)
Risk behavior (n=20)
 Use a shooting gallery to inject drug 7.5 (0.0–10.0) 0.0 (0.0–9.5)
 Utilize water previously used by another person 0.0 (0.0–6.7) 0.0 (0.0–1.7)
 Utilize cooker previously used by another person 5.0 (0.0–8.7) 0.0 (0.0–5.0)
 Utilize filter or cotton previously used by others 0.0 (0.0–6.7) 0.0 (0.0–0.0)
 Collect drug from a cooker after another person 0.0 (0.0–6.7) 0.0 (0.0–0.0)
 Back load their syringe 0.0 (0.0–5.2) 0.0 (0.0–0.0)
 Utilize other persons syringes 6.5 (2.5–9.0) 5.0 (2.5–10.0)
 Cleaning syringe with Clorox 10.0 (8.2–10.0) 10.0 (6.5–10.0)
HCV= Hepatitis C virus
IDUs=Injecting drug users
IQR= Inter quartile range
*
p value <.05 by Wilcoxon test
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Table 4
Results of Pre/Post testing: Measure of self confidence for HCV prevention
Parameter Pre-intervention Median (IQR) Post-intervention Median (IQR)
Measures (n=110)
Using their own syringe 10.0 (8.0–10.0) 10.0 (10.0–10.0)
Not permitting others to use their syringe 10.0 (9.0–10.0) 10.0 (10.0–10.0)
Not using others' filters or cottons 10.0 (7.0–10.0) 10.0 (10.0–10.0)
Utilizing water from their own recipients 10.0 (8.7–10.0) 10.0 (10.0–10.0)
Not permitting others to use their water recipients 10.0 (8.0–10.0) 10.0 (10.0–10.0)
Using a new cooker every time 10.0 (8.0–10.0) 10.0 (10.0–10.0)
Rejecting other back load their syringe 10.0 (6.0–10.0) 10.0 (10.0–10.0)
Using new syringes every time 10.0 (8.0–10.0) 10.0 (10.0–10.0)
Discarding water use to clean injecting instruments 10.0 (9.0–10.0) 10.0 (10.0–10.0)
Rejecting used filters or cookers 10.0 (7.0–10.0) 10.0 (9.0–10.0)
Cleaning syringes with Clorox after used them 10.0 (0.0–10.0) 9.0 (7.5–10.0)
Syringe disinfection, only if blood is not seen inside 10.0 (4.0–10.0) 7.0 (2.0–10.0)
HCV= Hepatitis C virus
IQR= Inter quartile range
*
p value <.05 by Wilcoxon test.
Ethn Dis. Author manuscript; available in PMC 2013 January 16.
